Strategies in the design of nanoparticles for therapeutic applications - PubMed (original) (raw)

Review

doi: 10.1038/nrd2591. Epub 2010 Jul 9.

Affiliations

• PMID: 20616808
• DOI: 10.1038/nrd2591

Review

Strategies in the design of nanoparticles for therapeutic applications

Robby A Petros et al. Nat Rev Drug Discov. 2010 Aug.

Abstract

Engineered nanoparticles have the potential to revolutionize the diagnosis and treatment of many diseases; for example, by allowing the targeted delivery of a drug to particular subsets of cells. However, so far, such nanoparticles have not proved capable of surmounting all of the biological barriers required to achieve this goal. Nevertheless, advances in nanoparticle engineering, as well as advances in understanding the importance of nanoparticle characteristics such as size, shape and surface properties for biological interactions, are creating new opportunities for the development of nanoparticles for therapeutic applications. This Review focuses on recent progress important for the rational design of such nanoparticles and discusses the challenges to realizing the potential of nanoparticles.

PubMed Disclaimer

Similar articles

• Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery.
  Verma S, Malviya R, Srivastava S, Ahmad I, Singh B, Almontasheri R, Uniyal P. Verma S, et al. Curr Pharm Des. 2024;30(33):2606-2618. doi: 10.2174/0113816128314618240628110218. Curr Pharm Des. 2024. PMID: 39034725 Review.
• Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.
  Otto DP, Otto A, de Villiers MM. Otto DP, et al. Expert Opin Drug Deliv. 2015 May;12(5):763-77. doi: 10.1517/17425247.2015.988135. Epub 2014 Dec 16. Expert Opin Drug Deliv. 2015. PMID: 25516397 Review.
• Synthetic and bioinspired cage nanoparticles for drug delivery.
  Deshayes S, Gref R. Deshayes S, et al. Nanomedicine (Lond). 2014 Jul;9(10):1545-64. doi: 10.2217/nnm.14.67. Nanomedicine (Lond). 2014. PMID: 25253501 Review.
• Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
  Ozeki T, Tagami T. Ozeki T, et al. Curr Pharm Des. 2013;19(35):6259-69. doi: 10.2174/1381612811319350004. Curr Pharm Des. 2013. PMID: 23470003 Review.
• Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
  Iqbal HMN, Rodriguez AMV, Khandia R, Munjal A, Dhama K. Iqbal HMN, et al. Recent Pat Inflamm Allergy Drug Discov. 2017;10(2):86-93. doi: 10.2174/1872213X10666161213162823. Recent Pat Inflamm Allergy Drug Discov. 2017. PMID: 27978790 Review.

Cited by

• A Single UV or Near IR Triggering Event Leads to Polymer Degradation into Small Molecules.
  de Gracia Lux C, McFearin CL, Joshi-Barr S, Sankaranarayanan J, Fomina N, Almutairi A. de Gracia Lux C, et al. ACS Macro Lett. 2012 Jul 17;1(7):922-926. doi: 10.1021/mz3002403. Epub 2012 Jul 9. ACS Macro Lett. 2012. PMID: 23066523 Free PMC article.
• Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach.
  Fang C, Kievit FM, Veiseh O, Stephen ZR, Wang T, Lee D, Ellenbogen RG, Zhang M. Fang C, et al. J Control Release. 2012 Aug 20;162(1):233-41. doi: 10.1016/j.jconrel.2012.06.028. Epub 2012 Jun 24. J Control Release. 2012. PMID: 22735239 Free PMC article.
• Development of Silica-Based Biodegradable Submicrometric Carriers and Investigating Their Characteristics as in Vitro Delivery Vehicles.
  Zyuzin MV, Zhu D, Parak WJ, Feliu N, Escudero A. Zyuzin MV, et al. Int J Mol Sci. 2020 Oct 13;21(20):7563. doi: 10.3390/ijms21207563. Int J Mol Sci. 2020. PMID: 33066289 Free PMC article.
• Rapid Brownian Motion Primes Ultrafast Reconstruction of Intrinsically Disordered Phe-Gly Repeats Inside the Nuclear Pore Complex.
  Moussavi-Baygi R, Mofrad MR. Moussavi-Baygi R, et al. Sci Rep. 2016 Jul 29;6:29991. doi: 10.1038/srep29991. Sci Rep. 2016. PMID: 27470900 Free PMC article.
• Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment.
  Portillo AL, Monteiro JK, Rojas EA, Ritchie TM, Gillgrass A, Ashkar AA. Portillo AL, et al. Front Immunol. 2023 Nov 8;14:1286750. doi: 10.3389/fimmu.2023.1286750. eCollection 2023. Front Immunol. 2023. PMID: 38022679 Free PMC article. Review.

References

1. 1. Cell Mol Life Sci. 2009 Sep;66(17):2873-96 - PubMed
2. 1. Crit Rev Ther Drug Carrier Syst. 1994;11(1):31-59 - PubMed
3. 1. J Nucl Med. 1972 Jul;13(7):498-503 - PubMed
4. 1. Pharm Res. 2009 Jan;26(1):244-9 - PubMed
5. 1. Pharm Res. 2009 Jan;26(1):235-43 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database